Delivery Order SPE2DB24D1205-SPE2DB25FCVPT
Award Date
4/7/25
Potential Completion Date
4/28/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,953.30, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 27, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,651.10, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific business type. In addition to this delivery order,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,604.40, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. AmerisourceBergen, a for-profit organization, is the prime contractor for this award, which is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,255.50, is a delivery order for the medical product "LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML". The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,640.10, is a delivery order for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award has a ceiling value of $13,953.30 and is a delivery order contract for the medical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a period of performance through March 19, 2025 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside requirement for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,197.41, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 16, 2024. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $8,789.64, is a Firm Fixed Price Delivery Order that does not have a set-aside designation. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to...
This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The award has a Firm Fixed Price contract type and a ceiling value of $4,651.10. The contract has an ultimate completion date of January 30, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $21,974.10 firm-fixed-price delivery order is for the supply of LEQVIO 284 MG/1.5 ML syringes. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities to...